Actively Recruiting
Postpartum Intervention for Mothers With Opioid Use Disorders
Led by Stony Brook University · Updated on 2024-12-16
50
Participants Needed
2
Research Sites
115 weeks
Total Duration
On this page
Sponsors
S
Stony Brook University
Lead Sponsor
U
University of Michigan
Collaborating Sponsor
AI-Summary
What this Trial Is About
Opioid use disorder (OUD) is a fast-growing and devastating epidemic in the US with many mothers suffering cravings, depression, impaired interpersonal interactions and maladaptive parenting behaviors that may lead to child maltreatment and costly utilization of foster care. This interdisciplinary multisite project will begin with the high risk R61 phase, in which the investigators will administer the parenting intervention "Mom Power" to mothers with OUD during the first 6 months postpartum and look for effects on drug use, mood and brain mechanisms; and, If validated, the investigators will continue in the R33 with more brain mechanism investigation and outcome studies a larger sample. The completion of this grant will clarify the effects of parenting intervention for mothers with OUD, and yield brain-based biomarkers that may be connected with inexpensive measures toward improved treatment of families suffering OUD, their children and society - which ultimately bears much of the cost for the common trans-generational problems of peripartum drug use.
CONDITIONS
Official Title
Postpartum Intervention for Mothers With Opioid Use Disorders
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Mothers aged 18 to 50 years from SBU or UM diagnosed with opioid use disorder (OUD) or receiving medication assisted treatment such as buprenorphine or methadone
- Have a child aged 5 years or younger
- Able to read, hear, and understand English adequately to provide informed consent
You will not qualify if you...
- Require immediate clinical care for suicidal or homicidal risk or psychosis
- For brain MRI, exclude if having ferromagnetic metal in the head
- Severe claustrophobia preventing participation in MRI
- Serious neurological conditions interfering with neuroimaging, such as brain tumor, multiple sclerosis, or significant head trauma
- Exclusion from MRI does not necessarily exclude from the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
University of Michigan
Ann Arbor, Michigan, United States, 48109
Actively Recruiting
2
Stony Brook University
Stony Brook, New York, United States, 11794
Actively Recruiting
Research Team
E
Elle Eggers, BSc
CONTACT
D
Diana Saum, MA, MSW
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here